s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Wednesday, April 21, 2021
Period
Jun 10, 2021
Accession number
0001564590-21-019817
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header